Online citations, reference lists, and bibliographies.
← Back to Search

Genetic Polymorphisms Of Human UDP-glucuronosyltransferase (UGT) Genes And Cancer Risk

D. G. Hu, P. Mackenzie, R. McKinnon, R. Meech
Published 2016 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Abstract Identification of genetic polymorphisms that contribute to the risk of developing cancers is important for cancer prevention. The most recent human genome GRCh38/hg38 assembly (2013) reveals thousands of genetic polymorphisms in human uridine diphosphoglucuronosyltransferase (UGT) genes. Among these, a large number of polymorphisms at the UGT1A and UGT2B genes have been shown to modulate UGT gene promoter activity or enzymatic activity. Glucuronidation plays an important role in the metabolism and clearance of endogenous and exogenous carcinogenic compounds, and this reaction is primarily catalyzed by the UGT1A and UGT2B enzymes. Therefore, it has long been hypothesized that UGT polymorphisms that reduce the capacity to glucuronidate carcinogens and other types of cancer-promoting molecules (e.g. sex hormones) are associated with an increased risk of developing cancers. A large number of case-control studies have investigated this hypothesis and these studies identified numerous UGT polymorphisms in UGT1A and UGT2B genes as genetic risk factors for a wide variety of cancers, including bladder, breast, colorectal, endometrial, esophageal, head and neck, liver, lung, prostate, and thyroid. These UGT polymorphisms may be cancer causative polymorphisms, or be linked to as yet undefined causative polymorphisms, either in UGT genes or neighboring genes. This article presents a comprehensive review of these case-control studies, discusses current areas of uncertainty, and highlights future research directions in this field.
This paper references
10.1016/j.gene.2011.04.001
Differential allelic expression of c.1568C > A at UGT2B15 is due to variation in a novel cis-regulatory element in the 3'UTR.
C. Sun (2011)
10.1038/sj.tpj.6500443
UGT1A7 polymorphisms in chronic pancreatitis: an example of genotyping pitfalls
R. Morsche (2008)
10.1007/BF00381244
Endogenous and exogenous factors in carcinogenesis: limits to cancer prevention
W. Lutz (1996)
10.1111/tbj.12304
Active Cigarette Smoking, Variants in Carcinogen Metabolism Genes and Breast Cancer Risk among Pre‐ and Postmenopausal Women in Ontario, Canada
M. Cotterchio (2014)
10.1053/GAST.2001.28655
Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene.
A. Vogel (2001)
10.1016/J.EJCA.2005.04.043
Polymorphism of UDP-glucuronosyltransferase 1A7 gene: a possible new risk factor for lung cancer.
J. Araki (2005)
10.1111/j.1572-0241.2005.41857.x
UDP-Glucuronosyltransferase 1A7 Genetic Polymorphisms Are Associated with Hepatocellular Carcinoma Risk and Onset Age
C. Tseng (2005)
10.1097/FPC.0b013e328323f66c
Genetic variations in UGT1A1 and UGT2B7 and endometrial cancer risk
M. McGrath (2009)
10.1089/GTE.2007.0020
Genetic polymorphisms in the UGT1A1 gene and breast cancer risk in Greek women.
A. Tsezou (2007)
Human UGT1A6
S 251659–1672. Nagar (2004)
10.1016/J.CDP.2007.07.005
The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case-control study in Caucasians.
C. Gallagher (2007)
10.1080/10408360802374624
Variability and Function of Family 1 Uridine-5′-Diphosphate Glucuronosyltransferases (UGT1A)
C. P. Strassburg (2008)
10.3322/caac.21262
Global cancer statistics, 2012
L. Torre (2015)
10.1006/TAAP.1999.8752
Effects of microsomal enzyme inducers on thyroid-follicular cell proliferation, hyperplasia, and hypertrophy.
A. Hood (1999)
10.1007/S11670-010-0260-Z
Polymorphisms of UGT1A7 and XRCC1 are associated with an increased risk of hepatocellular carcinoma in Northeast China
Zhi-fang Jia (2010)
Characterization of benzo(a)pyrene-trans-7,8-dihydrodiol glucuronidation by human tissue microsomes and overexpressed UDP-glucuronosyltransferase enzymes.
J. Fang (2002)
10.1089/gtmb.2012.0161
Association of uridine diphosphate-glucuronosyltransferase 2B gene variants with serum glucuronide levels and prostate cancer risk.
D. Grant (2013)
10.1002/ijc.20630
Breast cancer risk associated with genotype polymorphism of the catechol estrogen‐metabolizing genes: A multigenic study on cancer susceptibility
Ting-Chih Cheng (2005)
10.1182/blood-2010-07-294975
Inherited genetic susceptibility to monoclonal B-cell lymphocytosis.
Dalemari Crowther-Swanepoel (2010)
10.1124/dmd.109.030569
UDP-Glucuronosyltransferase 1A10: Activity against the Tobacco-Specific Nitrosamine, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, and a Potential Role for a Novel UGT1A10 Promoter Deletion Polymorphism in Cancer Susceptibility
R. Balliet (2010)
10.1016/j.soc.2015.03.004
Systemic therapy for squamous cell carcinoma of the head and neck.
P. Pancari (2015)
10.3892/OR.12.2.457
UGT1A1*28 polymorphism in ovarian cancer patients.
E. Cecchin (2004)
10.1093/jnci/djn485
Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.
B. Cole (2009)
Variability and function of family
CP Strassburg (2008)
10.1002/cncr.22634
Age‐specific association of steroid hormone pathway gene polymorphisms with breast cancer risk
D. Ralph (2007)
10.1007/s10549-010-0742-1
The association between TA-repeat polymorphism in the promoter region of UGT1A1 and breast cancer risk: a meta-analysis
L. Yao (2010)
10.1016/J.CDP.2006.04.004
Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population.
H. Okugi (2006)
10.1038/sj.tpj.6500449
Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate
A-H Karypidis (2008)
10.1155/2013/465916
UGT2B17 Polymorphism and Risk of Prostate Cancer: A Meta-Analysis
Marce-Amara Kpoghomou (2013)
10.1016/S0027-5107(02)00149-5
Metabolism of N-acetylbenzidine and initiation of bladder cancer.
T. Zenser (2002)
10.1210/ENDO.142.2.7958
Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members.
D. Turgeon (2001)
10.1006/TAAP.1994.1174
Reduction of thyroid hormone levels and alteration of thyroid function by four representative UDP-glucuronosyltransferase inducers in rats.
R. Barter (1994)
10.1093/CARCIN/BGM164
Glucuronidation of PhIP and N-OH-PhIP by UDP-glucuronosyltransferase 1A10.
R. Dellinger (2007)
Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
D. Hein (1993)
10.1074/jbc.M807961200
Identification of UDP Glycosyltransferase 3A1 as a UDP N-Acetylglucosaminyltransferase*
P. Mackenzie (2008)
10.1074/JBC.271.37.22855
Isolation and Characterization of a Novel cDNA Encoding a Human UDP-Glucuronosyltransferase Active on C19 Steroids*
M. Beaulieu (1996)
10.1093/JNCI/DJI066
Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma.
A. Chan (2005)
10.1371/journal.pone.0042873
UGT1A6 Polymorphisms Modulated Lung Cancer Risk in a Chinese Population
Ley-Fang Kua (2012)
Uridine diphosphoglucuronosyl
S 29043–51.Nagar (2006)
10.1097/00042737-199510000-00029
The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia.
W. Chow (1995)
Characterization and substrate specificity of UGT2B4 (E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene.
E. Levesque (1999)
Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man.
P. Bosma (1994)
10.1056/NEJMOA021735
A randomized trial of aspirin to prevent colorectal adenomas.
J. Baron (2003)
10.3109/03602530903205823
UGT3A: novel UDP-glycosyltransferases of the UGT superfamily
R. Meech (2010)
10.1038/bjc.2013.190
Fluid intake, genetic variants of UDP-glucuronosyltransferases, and bladder cancer risk
J. Wang (2013)
10.1038/nrc2795
Breast and prostate cancer: more similar than different
G. Risbridger (2010)
study of prostate cancer
H Maier (1992)
10.1093/TOXSCI/KFI068
An association of UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism with bladder cancer in benzidine-exposed workers in China.
G. Lin (2005)
10.1097/EDE.0b013e31812717fe
Cigarette Smoking and Lung Cancer: Modeling Effect Modification of Total Exposure and Intensity
J. Lubin (2007)
10.1097/01.FPC.0000174786.85238.63
No evidence that polymorphisms in CYP2C8, CYP2C9, UGT1A6, PPARδ and PPAR&ggr; act as modifiers of the protective effect of regular NSAID use on the risk of colorectal carcinoma
L. McGreavey (2005)
10.1159/000097908
Effects of Combined UDP-Glucuronosyltransferase (UGT) 1A1*28 and 1A6*2 on Paracetamol Pharmacokinetics in β-Thalassemia/HbE
Jeeranut Tankanitlert (2006)
10.1038/sj.tpj.6500171
Pharmacogenomics of human UDP-glucuronosyltransferase enzymes
C. Guillemette (2003)
10.1038/sj.onc.1209375
Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer
S. Nagar (2006)
10.1124/JPET.104.081968
UDP Glucuronosyltransferase (UGT) 1A6 Pharmacogenetics: II. Functional Impact of the Three Most Common Nonsynonymous UGT1A6 Polymorphisms (S7A, T181A, and R184S)
S. Krishnaswamy (2005)
10.1007/s00204-011-0690-5
Effect of UDP-glucuronosyltransferase 2B15 polymorphism on bisphenol A glucuronidation
N. Hanioka (2011)
10.1002/hed.23054
Combined effect of genetic polymorphisms in phase I and II biotransformation enzymes on head and neck cancer risk
M. Lacko (2013)
10.1134/S0026893306020075
Association of SULT1A1 and UGT1A1 polymorphisms with breast cancer risk and phenotypes in Russian women
E. Shatalova (2006)
10.1097/01.FPC.0000175596.52443.EF
Genotype–phenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomes
P. Lazarus (2005)
10.1016/0027-5107(93)90031-A
Carcinogenic factors in food with relevance to colon cancer development.
M. Nagao (1993)
10.1080/019262301301418838
Effects of Microsomal Enzyme Inducers on Thyroid Follicular Cell Proliferation and Thyroid Hormone Metabolism
C. Klaassen (2001)
10.1186/bcr936
Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview
C. Guillemette (2004)
UDPglucuronosyltransferase UGT1A7 genetic polymorphisms in hepatocellular carcinoma: A differential impact according to seropositivity of HBV or HCV markers? BMC Cancer 7:214
I Stucker (2007)
10.3322/caac.20107
Global cancer statistics
A. Jemal (2011)
10.5812/numonthly.9430
Molecular Pathways in Prostate Cancer
E. Mazaris (2013)
10.1097/00008571-199708000-00001
The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.
P. Mackenzie (1997)
10.1016/J.CGH.2006.04.021
Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention.
W. Samowitz (2006)
10.1023/A:1026349702909
A pooled analysis of case–control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea
W. Mack (2004)
10.1056/NEJMOA021633
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
R. Sandler (2003)
10.1124/dmd.108.022731
The Configuration of the 17-Hydroxy Group Variably Influences the Glucuronidation of β-Estradiol and Epiestradiol by Human UDP-Glucuronosyltransferases
Katriina Itäaho (2008)
Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans.
C. Guillemette (2000)
10.1007/s10434-000-0777-3
An Allele-Specific Polymerase Chain Reaction Method for the Determination of the D85Y Polymorphism in the Human UDPGlucuronosyltransferase 2B15 Gene in a Case-Control Study of Prostate Cancer
S. Macleod (2000)
10.1373/clinchem.2010.151043
Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease.
J. Lin (2010)
10.1159/000343828
Treatment of Hepatocellular Carcinoma: A Systematic Review
S. Lin (2012)
10.3727/096504009787721203
Genetic polymorphism in UDP-glucuronosyltransferase 2B7 and colorectal cancer risk.
E. M. J. van der Logt (2009)
10.1093/CARCIN/20.10.1963
Glucuronidation of benzidine and its metabolites by cDNA-expressed human UDP-glucuronosyltransferases and pH stability of glucuronides.
M. Ciotti (1999)
10.1124/DMD.30.4.397
Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues.
Zhong Zheng (2002)
10.1158/1940-6207.CAPR-11-0337
The Influence of UGT1A6 Variants and Aspirin Use in a Randomized Trial of Celecoxib for Prevention of Colorectal Adenoma
A. Chan (2011)
10.1007/s12199-012-0302-x
Association of genotypes of carcinogen-metabolizing enzymes and smoking status with bladder cancer in a Japanese population
Xiaoyi Cui (2012)
[Association of polymorphisms in SULT1A1 and UGT1A1 Genes with breast cancer risk and phenotypes in Russian women].
E. Shatalova (2006)
10.1124/JPET.104.067660
UDP-Glucuronosyltransferase (UGT) 2B15 Pharmacogenetics: UGT2B15 D85Y Genotype and Gender Are Major Determinants of Oxazepam Glucuronidation by Human Liver
M. Court (2004)
10.1007/BF00184668
Tobacco and alcohol and the risk of head and neck cancer
H. Maier (2004)
10.1158/1055-9965.EPI-06-0831
Ovarian Cancer Risk and Polymorphisms Involved in Estrogen Catabolism
S. Holt (2007)
10.2174/092986612798472848
Prostate cancer with variants in CYP17 and UGT2B17 genes: a meta-analysis.
L. Cai (2012)
10.1124/jpet.112.202242
Refining the UGT1A Haplotype Associated with Irinotecan-Induced Hematological Toxicity in Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil/Irinotecan-Based Regimens
E. Levesque (2013)
The changing epidemiology of esophageal cancer.
W. Blot (1999)
10.1093/CARCIN/14.12.2637
The glucuronidation of hydroxylated metabolites of benzo[a]pyrene and 2-acetylaminofluorene by cDNA-expressed human UDP-glucuronosyltransferases.
C. Jin (1993)
10.1097/01.JU.0000117748.44313.43
Asp85tyr polymorphism in the udp-glucuronosyltransferase (UGT) 2B15 gene and the risk of prostate cancer.
J. Park (2004)
10.1002/cncr.28009
The effect of copy number variation in the phase II detoxification genes UGT2B17 and UGT2B28 on colorectal cancer risk
Andrea Y. Angstadt (2013)
10.1006/GENO.1996.0242
The human gene CGT encoding the UDP-galactose ceramide galactosyl transferase (cerebroside synthase): cloning, characterization, and assignment to human chromosome 4, band q26.
A. Bosio (1996)
10.1093/AJE/KWM204
Alcohol drinking, tobacco smoking, and anthropometric characteristics as risk factors for thyroid cancer: a countrywide case-control study in New Caledonia.
R. Guignard (2007)
10.1093/JNCI/DJJ360
Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk.
T. Rebbeck (2006)
10.1124/JPET.104.081950
UDP Glucuronosyltransferase (UGT) 1A6 Pharmacogenetics: I. Identification of Polymorphisms in the 5′-Regulatory and Exon 1 Regions, and Association with Human Liver UGT1A6 Gene Expression and Glucuronidation
S. Krishnaswamy (2005)
Diet and Health Study
CL Meinhold (2010)
10.1158/1055-9965.EPI-05-0863
Cigarette Smoking and Lung Cancer: Modeling Total Exposure and Intensity
J. Lubin (2006)
10.1093/CARCIN/20.6.1107
Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4, 5-b]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involved.
S. Nowell (1999)
10.1038/ng1696
Common deletion polymorphisms in the human genome
S. McCarroll (2006)
10.1038/nrc1190
Tobacco carcinogens, their biomarkers and tobacco-induced cancer
S. Hecht (2003)
10.1002/cncr.11587
Detection of UGT1A10 polymorphisms and their association with orolaryngeal carcinoma risk
A. Elahi (2003)
10.3760/CMA.J.ISSN.0376-2491.2009.44.007
[Association between genetic polymorphism of UGT1A7 and susceptibility of bladder cancer].
J. Liu (2009)
10.1002/pros.20700
The UGT2B17 gene deletion is not associated with prostate cancer risk
M. Olsson (2008)
10.1124/dmd.105.009100
IMPORTANCE OF UDP-GLUCURONOSYLTRANSFERASE 1A10 (UGT1A10) IN THE DETOXIFICATION OF POLYCYCLIC AROMATIC HYDROCARBONS: DECREASED GLUCURONIDATIVE ACTIVITY OF THE UGT1A10139LYS ISOFORM
R. Dellinger (2006)
10.1097/01.FPC.0000173483.13689.56
Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily.
P. Mackenzie (2005)
Breast cancer risk associated with genotype polymorphism of the catechol
TC Cheng (2005)
10.1097/01.FPC.0000114771.78957.CB
Human UGT1A6 pharmacogenetics: identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells.
S. Nagar (2004)
10.1111/j.1440-1746.2005.04032.x
Genetic polymorphisms of the uridine diphosphate glucuronosyltransferase 1A7 and colorectal cancer risk in relation to cigarette smoking and alcohol drinking in a Chinese population
K. Chen (2006)
10.3109/03602532.2014.973037
Transcriptional regulation of human UDP-glucuronosyltransferase genes
D. G. Hu (2014)
10.1016/J.ENVRES.2007.07.002
The multitude and diversity of environmental carcinogens.
D. Belpomme (2007)
10.1136/gut.50.6.851
Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer
C. Strassburg (2002)
10.1016/J.SEMCANCER.2004.06.010
Environmental and chemical carcinogenesis.
G. Wogan (2004)
10.1007/s00204-012-0854-y
Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk
S. Selinski (2012)
10.1093/JNCI/93.18.1411
Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk.
Z. Zheng (2001)
10.1023/A:1013794407325
Serum bilirubin and 10-year mortality risk in a Belgian population
E. H. Temme (2004)
10.1158/1055-9965.EPI-04-0682
Joint Effects between UDP-Glucuronosyltransferase 1A7 Genotype and Dietary Carcinogen Exposure on Risk of Colon Cancer
L. Butler (2005)
10.4103/0973-1075.100820
A Comprehensive Review of Head and Neck Cancer Rehabilitation: Physical Therapy Perspectives
K. Guru (2012)
Carcinogenic factors in food
T. Sugimura (1993)
10.1158/1078-0432.CCR-06-0903
Genetic Variants of UGT1A6 Influence Risk of Colorectal Adenoma Recurrence
R. Hubner (2006)
10.1093/CARCIN/20.8.1577
Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse.
P. Upadhyaya (1999)
10.1093/carcin/bgr139
Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
Li Tang (2011)
10.1016/0006-2952(95)00095-H
Formation of mono- and diglucuronides and other glycosides of benzo(a)pyrene-3,6-quinol by V79 cell-expressed human phenol UDP-glucuronosyltransferases of the UGT1 gene complex.
Harald Gschaidmeier (1995)
Molecular pathways in prostate
E 171137–1144. Mazaris (2013)
Genetic variations
M 3886–92. McGrath (2009)
10.1007/s00439-011-1025-6
A signature of balancing selection in the region upstream to the human UGT2B4 gene and implications for breast cancer risk
Chang Sun (2011)
10.1056/NEJMRA050776
Estrogen carcinogenesis in breast cancer.
J. Yager (2006)
Genotypephenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomes
P Lazarus (2005)
10.1093/HUMUPD/7.3.273
Genotoxicity of the steroidal oestrogens oestrone and oestradiol: possible mechanism of uterine and mammary cancer development.
J. Liehr (2001)
10.1006/BBRC.2002.6683
Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.
J. Sugatani (2002)
10.1016/S0960-0760(99)00088-6
Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7
Walter E. Gall (1999)
10.1016/j.cancergen.2012.01.015
Promoter length polymorphism in UGT1A1 and the risk of sporadic colorectal cancer.
Marija Hiljadnikova Bajro (2012)
10.1038/sj.bjc.6605337
Alcohol intake and risk of thyroid cancer in the NIH-AARP Diet and Health Study
C. Meinhold (2009)
10.1111/j.1601-0825.2010.01683.x
Polymorphisms in CYP2A13 and UGT1A7 genes and head and neck cancer susceptibility in North Indians.
R. Sharma (2010)
10.1371/journal.pone.0000396
Searching for Tissue-Specific Expression Pattern-Linked Nucleotides of UGT1A Isoforms
Wei Zhang (2007)
10.1093/CARCIN/BGH251
Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk.
E. M. J. van der Logt (2004)
10.1158/0008-5472.CAN-03-3219
Correlation between UDP-Glucuronosyltransferase Genotypes and 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone Glucuronidation Phenotype in Human Liver Microsomes
D. Wiener (2004)
10.3892/ijo.2012.1385
High enzyme activity UGT1A1 or low activity UGT1A8 and UGT2B4 genotypes increase esophageal cancer risk.
P. Dura (2012)
10.1016/S0065-2423(06)43001-8
The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases.
L. Vítek (2007)
10.1016/j.mrfmmm.2008.07.002
UGT1A1 and UGT1A9 functional variants, meat intake, and colon cancer, among Caucasians and African-Americans.
H. Girard (2008)
Alteration of thyroid homeostasis by UDP-glucuronosyltransferase inducers in rats: a dose-response study.
J. Liu (1995)
10.1124/DMD.30.11.1257
Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTs): S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9.
M. Court (2002)
10.1021/TX049898M
Human UDP-glucuronosyltransferase 1A1 is the primary enzyme responsible for the N-glucuronidation of N-hydroxy-PhIP in vitro.
M. Malfatti (2004)
10.1097/00008571-200010000-00006
Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene.
C. Guillemette (2000)
Endogenous carcinogenesis: molecular oncology into the twenty-first century--presidential address.
L. Loeb (1989)
10.1016/J.UROLOGY.2007.03.001
Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk.
J. Park (2007)
10.1038/pr.2014.115
UGT1A1*28 polymorphism and acute lymphoblastic leukemia in children: a Danish case–control study
J. Petersen (2014)
10.1038/nrc1934
Hepatocellular carcinoma pathogenesis: from genes to environment
Paraskevi A. Farazi (2006)
CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk.
J. Bigler (2001)
10.1158/0008-5472.CAN-03-3295
The Functional UGT1A1 Promoter Polymorphism Decreases Endometrial Cancer Risk
Y. Duguay (2004)
O-Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanol (NNAL) by human UDP-glucuronosyltransferases 2B7 and 1A9.
Q. Ren (2000)
10.1097/CEJ.0b013e328350b04c
Effects of cytochrome P450 1A1 and uridine-diphosphate-glucuronosyltransferase 1A1 allelic polymorphisms on the risk of development and the prognosis of head and neck cancers
I. Szanyi (2012)
10.1002/ijc.27412
Association of serum bilirubin and promoter variations in HMOX1 and UGT1A1 genes with sporadic colorectal cancer
A. Jirásková (2012)
10.3322/canjclin.49.1.33
Global cancer statistics
D. Parkin (1999)
10.1038/ng.687
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci
N. Rothman (2010)
10.1021/TX980005Y
Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines.
S. Hecht (1998)
10.1111/j.1365-2141.2010.08270.x
Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk
Dalemari Crowther-Swanepoel (2010)
Relevance of UDPglucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review
JC Stingl (2014)
10.1158/1055-9965.EPI-06-0823
The UDP-Glucuronosyltransferase 2B17 Gene Deletion Polymorphism: Sex-Specific Association with Urinary 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol Glucuronidation Phenotype and Risk for Lung Cancer
C. Gallagher (2007)
10.1002/gcc.22167
Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: Colon cancer family registry
D. Scherer (2014)
10.3389/fonc.2014.00106
Estrogen Signaling and the DNA Damage Response in Hormone Dependent Breast Cancers
C. E. Caldon (2014)
The UDPglucuronosyltransferase 2B17 gene deletion polymorphism: Sex-specific association with urinary 4-(methylnitrosamino)1-(3-pyridyl)-1-butanol glucuronidation phenotype and risk for lung cancer
CJ Gallagher (2007)
10.1158/1055-9965.EPI-07-0752
UGT1A1 Genetic Polymorphisms, Endogenous Estrogen Exposure, Soy Food Intake, and Endometrial Cancer Risk
S. Deming (2008)
10.3389/fgene.2013.00104
The UGT1A6_19_GG genotype is a breast cancer risk factor
Christina Justenhoven (2013)
10.1124/MOL.52.2.212
Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue.
C. P. Strassburg (1997)
10.1055/s-0029-1242458
Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors.
F. Haggar (2009)
10.1111/j.1349-7006.2007.00693.x
UGT1A7 haplotype is associated with an increased risk of hepatocellular carcinoma in hepatitis B carriers
Sun-Young Kong (2008)
10.1002/gcc.22157
The effect of UGT1A and UGT2B polymorphisms on colorectal cancer risk: Haplotype associations and gene–environment interactions
Andrea Y. Angstadt (2014)
10.1124/MOL.59.3.405
Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract.
R. Tukey (2001)
10.1056/NEJM199511023331802
The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.
P. Bosma (1995)
10.1111/j.1464-410X.2008.07961.x
Epidemiology and genetic susceptibility to bladder cancer
X. Wu (2008)
10.1055/S-2002-32805
Polymorphisms of the carcinogen detoxifying UDP-glucuronosyltransferase UGT1A7 in proximal digestive tract cancer.
A. Vogel (2002)
10.1002/ijc.25296
Genetic polymorphism in the conjugating enzyme UGT1A1 and the risk of head and neck cancer
M. Lacko (2010)
10.1080/10408360802374624
Variability and function of family 1 uridine-5'-diphosphate glucuronosyltransferases (UGT1A).
C. Strassburg (2008)
10.1023/B:BREA.0000025419.26423.b8
Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer
O. Adegoke (2004)
10.1093/aje/kwp354
Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study.
C. Meinhold (2010)
10.1016/S0140-6736(96)91273-8
Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome
G. Monaghan (1996)
10.1186/1471-2407-13-556
Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study
A. Vidal (2013)
10.1515/CCLM.2000.129
Polymorphisms in UDP Glucuronosyltransferase Genes: Functional Consequences and Clinical Relevance
P. Mackenzie (2000)
10.1093/hmg/ddr619
Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer.
W. Tang (2012)
Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium.
C. P. Strassburg (1998)
10.1080/15287390801988772
UDP-Glucuronosyltransferase 2B7 C802T (His268Tyr) Polymorphism in Bladder Cancer Cases
A. Zimmermann (2008)
10.1016/S0168-8278(00)80268-8
Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene.
M. Raijmakers (2000)
10.1016/J.EJCA.2007.08.006
DNA-repair and carcinogen-metabolising enzymes genetic polymorphisms as an independent risk factor for hepatocellular carcinoma in Caucasian liver-transplanted patients.
P. Borentain (2007)
10.1016/j.canep.2010.02.009
Genetic polymorphisms in the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene and prostate cancer risk in Caucasian men.
A. Karatzas (2010)
10.1042/BJ3380489
Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus.
C. P. Strassburg (1999)
10.1124/dmd.111.039149
UGT1A6 and UGT2B15 Polymorphisms and Acetaminophen Conjugation in Response to a Randomized, Controlled Diet of Select Fruits and Vegetables
Sandi L Navarro (2011)
OGlucuronidation of the lung carcinogen 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanol (NNAL) by human 2B7 and 1A9
Q Ren (2000)
UGT1A6 and UGT2B15
SL Navarro (2011)
10.1016/j.clpt.2003.10.006
A novel functional polymorphism in the uridine diphosphate–glucuronosyltransferase 2B7 promoter with significant impact on promoter activity
Y. Duguay (2004)
10.1007/s10549-007-9720-7
Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and breast cancer risk in Africans
D. Huo (2007)
Differential allelic expression of c.1568C4A at UGT2B15 is due to variation in a novel cis-regulatory element in the 30UTR. Gene 481:24–28
C Sun (2011)
10.3109/07357907.2011.626477
Genetic Polymorphisms of UGT1A7 and Cancer Risk: Evidence From 21 Case–Control Studies
Pei-hua Lu (2011)
10.1016/j.canep.2012.02.004
The association between UGT1A7 polymorphism and cancer risk: a meta-analysis.
Shuang-Xi Han (2012)
10.1002/humu.21054
Copy‐number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism
V. Ménard (2009)
10.1159/000355714
UGT1A1*28 Polymorphism in Chronic Lymphocytic Leukemia: The First Investigation of the Polymorphism in Disease Susceptibility and Its Specific Cytogenetic Abnormalities
M. Karakosta (2014)
10.1053/j.gastro.2011.03.036
Genotyping of the UDP-glucuronosyltransferase (UGT) 1A7 gene revisited.
A. Vogel (2011)
10.1158/1055-9965.EPI-09-1018
Genetic Variation of Genes Involved in Dihydrotestosterone Metabolism and the Risk of Prostate Cancer
S. Setlur (2010)
[Correlation of polymorphisms of UDP-glucuronosyltransferase 1A7 gene to genetic susceptibility of lung cancer].
F. Feng (2005)
10.1097/01.fpc.0000236339.79916.07
UGT1A6 polymorphism and salicylic acid glucuronidation following aspirin
Y. Chen (2007)
10.1124/mol.114.093823
A Novel Function for UDP Glycosyltransferase 8: Galactosidation of Bile Acids
R. Meech (2015)
10.1016/S0300-483X(02)00449-3
Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance.
J. Miners (2002)
10.1007/s10549-009-0407-0
Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women
The MARIE-GENICA Consortium on Genetic Susceptibility Risk (2009)
Glucuronidation of carcinogen metabolites by complementary DNA-expressed uridine 5'-diphosphate glucuronosyltransferases.
P. Mackenzie (1993)
10.1210/JC.2004-0331
Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium.
Johanie Lépine (2004)
10.5858/arpa.2014-0554-RA
Epigenetic Mechanisms of Human Papillomavirus-Associated Head and Neck Cancer.
Nicole V Anayannis (2015)
10.1158/0008-5472.CAN-12-2388
Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer.
M. García-Closas (2013)
10.3748/WJG.15.2240
No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk.
Cheryl-L Thompson (2009)
10.1016/j.jsbmb.2008.03.016
Inactivation by UDP-glucuronosyltransferase enzymes: The end of androgen signaling
S. Chouinard (2008)
10.1158/1078-0432.CCR-1187-3
UDP-Glucuronosyltransferase 1A7 Genetic Polymorphisms Are Associated with Hepatocellular Carcinoma in Japanese Patients with Hepatitis C Virus Infection
Y. Wang (2004)
10.1124/dmd.113.056630
Polymorphisms and Haplotypes of the UDP-Glucuronosyltransferase 2B7 Gene Promoter
D. G. Hu (2014)
10.1007/s100380200075
Catalog of 86 single-nucleotide polymorphisms (SNPs) in three uridine diphosphate glycosyltransferase genes: UGT2A1, UGT2B15, and UGT8
A. Iida (2002)
10.1007/s10549-010-1093-7
Combined UGT1A1 and UGT1A6 genotypes together with a stressful life event increase breast cancer risk
Christina Justenhoven (2010)
10.1111/j.1349-7006.2004.tb03205.x
Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish
T. Sugimura (2004)
10.1016/j.canep.2013.06.004
UDP-glucuronosyltransferase 2B17 genotype and the risk of lung cancer among Austrian Caucasians.
Michaela Gruber (2013)
10.1097/00008571-199906000-00009
UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations.
J. Lampe (1999)
10.3322/caac.21254
Cancer statistics, 2015
R. Siegel (2015)
10.1186/bcr1318
Genetic polymorphisms in human SULT1A1 and UGT1A1 genes associate with breast tumor characteristics: a case-series study
E. Shatalova (2005)
10.1021/tx900436m
A comprehensive approach to the profiling of the cooked meat carcinogens 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, and their metabolites in human urine.
D. Gu (2010)
An allelespecific polymerase chain reaction method for the determination of the D85Y polymorphism in the human
SL MacLeod (2000)
10.1006/TOXS.1998.2494
Glucuronidation of catechol estrogens by expressed human UDP-glucuronosyltransferases (UGTs) 1A1, 1A3, and 2B7.
Z. Cheng (1998)
10.1186/1471-2407-7-214
UDP-glucuronosyltransferase UGT1A7 genetic polymorphisms in hepatocellular carcinoma: a differential impact according to seropositivity of HBV or HCV markers?
I. Stücker (2007)
Pharmacogenomics of human UDPglucuronosyltransferase enzymes
C. Guillemette (2003)
10.1124/dmd.105.005652
GLUCURONIDATION OF THE ASPIRIN METABOLITE SALICYLIC ACID BY EXPRESSED UDP-GLUCURONOSYLTRANSFERASES AND HUMAN LIVER MICROSOMES
Gwendolyn E. Kuehl (2006)
10.1124/DMD.32.1.72
Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human liver: importance of UDP-glucuronosyltransferase 1A4.
D. Wiener (2004)
Genetic polymorphism in the human UGT1A6 (planar phenol) UDPglucuronosyltransferase: Pharmacological implications
M Ciotti (1997)
10.1002/ijc.10728
Association of genotypes of carcinogen‐activating enzymes, phenol sulfotransferase SULT1A1 (ST1A3) and arylamine N‐acetyltransferase NAT2, with urothelial cancer in a Japanese population
S. Ozawa (2002)
Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels.
C. Guillemette (2001)
10.3748/WJG.V11.I21.3250
Link between colorectal cancer and polymorphisms in the uridine-diphosphoglucuronosyltransferase 1A7 and 1A1 genes.
K. Tang (2005)
Metabolism of Thyroid Hormone
T. Visser (2012)
10.1186/bcr818
UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients
R. Sparks (2004)
10.1182/blood-2008-03-148874
Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis.
V. Ribrag (2009)
10.1124/mol.110.069336
The Novel UDP Glycosyltransferase 3A2: Cloning, Catalytic Properties, and Tissue Distribution
P. Mackenzie (2011)
10.3322/caac.21174
Cancer screening in the United States, 2013
R. Smith (2013)
10.1371/journal.pone.0069367
Genetic Variants in Hormone-Related Genes and Risk of Breast Cancer
T. Clendenen (2013)
10.1002/humu.21145
Allelic imbalance (AI) identifies novel tissue‐specific cis‐regulatory variation for human UGT2B15
C. Sun (2010)
10.1093/CARCIN/21.3.387
Nutrition and dietary carcinogens.
T. Sugimura (2000)
10.1158/1055-9965.EPI-06-0141
Deletion Polymorphism of UDP-Glucuronosyltransferase 2B17 and Risk of Prostate Cancer in African American and Caucasian Men
J. Park (2006)
10.1002/HEP.1840400412
Serum bilirubin levels in the U.S. Population: Gender effect and inverse correlation with colorectal cancer
S. Zucker (2004)
10.1073/PNAS.95.14.8170
Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?
E. Beutler (1998)
10.1158/0008-5472.CAN-05-2857
Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone.
Jean Thibaudeau (2006)
10.1006/RTPH.2001.1521
An analysis of the mainstream smoke chemistry of samples of the U.S. cigarette market acquired between 1995 and 2000.
J. E. Swauger (2002)
10.1097/00008571-199708000-00007
Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene.
E. Levesque (1997)
10.1002/hed.21090
Genetic polymorphisms in the tobacco smoke carcinogens detoxifying enzyme UGT1A7 and the risk of head and neck cancer
M. Lacko (2009)
A polymorphism in the UDP-Glucuronosyltransferase 2B15 gene (D85Y) is not associated with prostate cancer risk.
A. Gsur (2002)
10.1097/00001648-200001000-00011
Risk of papillary thyroid cancer in women in relation to smoking and alcohol consumption.
M. A. Rossing (2000)
10.1530/ERC-11-0372
Common genetic variants in metabolism and detoxification pathways and the risk of papillary thyroid cancer.
B. Aschebrook-Kilfoy (2012)
10.1111/j.1365-2125.2008.03103.x
UGT1A6 genotype-related pharmacokinetics of deferiprone (L1) in healthy volunteers.
L. M. G. Limenta (2008)
10.1016/j.pharmthera.2013.09.002
Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review.
J. Stingl (2014)
10.1097/00008571-199712000-00007
Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications.
M. Ciotti (1997)
10.1124/mol.110.065953
A Novel Polymorphism in a Forkhead Box A1 (FOXA1) Binding Site of the Human UDP Glucuronosyltransferase 2B17 Gene Modulates Promoter Activity and Is Associated with Altered Levels of Circulating Androstane-3α,17β-diol Glucuronide
D. G. Hu (2010)
Isolation and characterization of a novel cDNA encoding a human
M Beaulieu (1996)



This paper is referenced by
10.2147/CMAR.S179467
Identification of key genes and specific pathways potentially involved in androgen-independent, mitoxantrone-resistant prostate cancer
S. Zhu (2019)
10.1016/j.xphs.2017.04.073
Disturbance of Mammary UDP-Glucuronosyltransferase Represses Estrogen Metabolism and Exacerbates Experimental Breast Cancer.
X. Zhou (2017)
10.1002/cbic.201900065
Coupled Enzymatic Treatment and Mass Spectrometric Analysis for Identification of Glucuronidated Metabolites in Human Samples
Mario S P Correia (2019)
10.1007/s42000-020-00213-x
The function of uterine UDP-glucuronosyltransferase 1A8 (UGT1A8) and UDP-glucuronosyltransferase 2B7 (UGT2B7) is involved in endometrial cancer based on estrogen metabolism regulation
Fu-Geng Zhao (2020)
10.1158/1055-9965.EPI-19-0449
Expression Patterns of Xenobiotic-Metabolizing Enzymes in Tumor and Adjacent Normal Mucosa Tissues among Patients with Colorectal Cancer: The ColoCare Study
Jolantha Beyerle (2019)
Cysteine uptake capacity is a relevant mechanism of resistance to platinum salts, in ovarian cancer
I. Santos (2018)
10.1111/cas.14635
UDP‐glucuronosyltransferase polymorphisms affect diethylnitrosamine‐induced carcinogenesis in humanized transgenic mice
Steffen Landerer (2020)
10.1016/j.phrs.2016.12.008
Advances in drug metabolism and pharmacogenetics research in Australia
P. Mackenzie (2017)
10.1186/s12885-017-3463-6
UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression
D. Grant (2017)
10.1152/physrev.00058.2017
The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms.
R. Meech (2019)
10.1080/10937404.2017.1304719
Urinary bladder cancer risk factors in an area of former coal, iron, and steel industries in Germany
Eugen Krech (2017)
10.1007/978-981-13-5877-7_14
Molecular Biomarkers and Urinary Bladder Cancer (UBC)
A. Srivastava (2019)
10.1080/15592294.2020.1795601
Expression of UDP Glucuronosyltransferases 2B15 and 2B17 Is Associated with Methylation Status in Prostate Cancer cells.
Farideh Shafiee-Kermani (2020)
10.1002/ijc.31917
Association of breast cancer risk with polymorphisms in genes involved in the metabolism of xenobiotics and interaction with tobacco smoking: A gene‐set analysis
T. Berrandou (2019)
10.3390/ijms20061463
A Systematic Review of Phytochemistry, Pharmacology and Pharmacokinetics on Astragali Radix: Implications for Astragali Radix as a Personalized Medicine
Z. Guo (2019)
10.1124/dmd.118.082024
Content and Activities of UGT2B7 in Human Liver In Vitro and Predicted In Vivo: A Bottom-Up Approach
C. Xu (2018)
10.1002/kjm2.12077
Effect of UDP‐glucuronosyltransferase 1A1 activity on risk for developing Gilbert's syndrome
May-Jen Huang (2019)
10.2217/pgs-2020-0049
Pharmacogenetic score predicts overall survival, progression-free survival and platinum sensitivity in ovarian cancer.
S. Gagno (2020)
10.3390/jcm8030393
Current Progress in Pharmacogenetics of Second-Line Antidiabetic Medications: Towards Precision Medicine for Type 2 Diabetes
Chan Heo (2019)
Correlation between miRNA-196 a 2 and miRNA-499 polymorphisms and bladder cancer
J. Wang (2016)
10.18502/IJPH.V49I1.3052
Impaired Metabolic Pathways Related to Colorectal Cancer Progression and Therapeutic Implications
Chun-yan Qiu (2020)
10.1002/jcph.1493
Characterization of the Ontogeny of Hepatic UDP‐Glucuronosyltransferase Enzymes Based on Glucuronidation Activity Measured in Human Liver Microsomes
Justine Badée (2019)
10.1002/biot.201800002
Chemical Probes for Human UDP‐Glucuronosyltransferases: A Comprehensive Review
Xia Lv (2019)
10.1016/j.jaad.2018.05.1251
12‐Hydroxyeicosatetraenoic acid levels are increased in actinic keratoses and squamous cell carcinoma
V. Laquer (2018)
10.1038/s41598-017-15033-0
Modification of single-nucleotide polymorphism in a fully humanized CYP3A mouse by genome editing technology
S. Abe (2017)
Genetic polymorphisms in the drug detoxification genes and susceptibility to Urinary Bladder Cancer (UBC)
K. Gautam (2018)
10.1038/s41416-019-0722-0
Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression
Éric P. Allain (2020)
10.1016/j.pharmthera.2019.107414
The UGTome: the expanding diversity of UDP glycosyltransferases and its impact on small molecule metabolism.
D. G. Hu (2019)
10.1111/liv.13454
UGT1As and predisposition to liver cancer: Still important, more elusive
P. Pineau (2017)
10.1016/j.phrs.2017.05.001
UDP-glucuronosyltransferases (UGTs) and their related metabolic cross-talk with internal homeostasis: A systematic review of UGT isoforms for precision medicine.
N. Yang (2017)
10.1002/jcp.26289
Molecular mechanisms of drug resistance in ovarian cancer
Leyla Norouzi-Barough (2018)
10.1124/dmd.118.084368
A Novel Pathogenic UGT1A1 Variant in a Sudanese Child with Type 1 Crigler-Najjar Syndrome
Walaa Elfar (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar